#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Piriformis syndrome Lupus nephritis Adrenoleukodystrophy Glomerulonephritis membranoproliferative Insulinoma Cardiac amyloidosis Anaplastic large cell lymphoma T- and null-cell types Leukocyte adhesion deficiency type I Mastocytosis Stiff person syndrome Acute myeloid leukaemia (in remission) Hereditary angioedema Glioblastoma Chronic myeloid leukaemia (in remission) Leukodystrophy More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Treatment Focal segmental glomerulosclerosis – Trials in Disease Ewing’s sarcoma metastatic – Diagnostics Haemophilia B with anti factor IX – Basic Information Haemophilia A without inhibitors Lymphangiosarcoma – Treatment Mastocytosis – Diagnostics Piriformis syndrome – Diagnostics Phenylketonuria – Life with Disease Netherton’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meglumine Gadoterate Carfilzomib Anhydrous Cidofovir Siplizumab Icatibant Iti-1284 Isoleucine Patritumab Deruxtecan Flutemetamol (18F) Cart45Ra-Nkg2D Cells METHYLPHENIDATE Nanatinostat Calcium Levofolinate Cariprazine Adalimumab Selatogrel Oregovomab Mexiletine Mirabegron [18F]Fluoro-Peg-Folate More therapies…

    Learn about Your Condition

    Choroidal dystrophy Brain cancer metastatic Multiple sclerosis Constipation Carcinoid syndrome Febrile neutropenia Urethral valves Acute myeloid leukaemia Prostatitis Escherichia coli Fabry's disease Hepatic fibrosis Pancreatitis acute Renal cancer recurrent Uterine leiomyoma Testicular leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Region Oestergoetland

Region Oestergoetland

Universitetssjukhuset I Linkoping, Linkoping, 581 85, Sweden

Want to learn more about this study or check if you can participate? Contact us.

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Dactinomycin
    • Regorafenib
    • Vinorelbine Tartrate
    Austria Belgium Czechia Denmark Finland France +10

  • Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Dostarlimab
    • Capecitabine
    • Fluorouracil
    Belgium Czechia Estonia Finland France Germany +8

  • Study Comparing Chemoradiotherapy with Fluorouracil, Cisplatin, and Carboplatin for Patients with Operable Esophageal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Fluorouracil
    France Ireland Norway Sweden

  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Atrial fibrillation
    • Chronic kidney disease
    Investigated Drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Cyclophosphamide Monohydrate
    Austria Belgium Czechia Denmark Finland France +13

  • Study on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glomerulonephritis rapidly progressive
    Investigated Drugs:
    • Lixudebart
    • Rituximab
    Czechia Denmark France Germany Italy Spain +1

  • Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Denmark Estonia Finland Italy Norway Sweden

  • Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epcoritamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Ibrutinib
    • Obinutuzumab
    • Venetoclax
    Austria Belgium Denmark Finland Germany Ireland +5

  • Study on Rituximab and Drug Combination for Treating Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Vinblastine Sulfate
    • Abiraterone Acetate
    • Dexamethasone Acetate
    Austria Czechia Denmark Finland Germany Norway +1
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!